These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18656457)

  • 21. PTK, MAPK, and NOC/oFQ impair hypercapnic cerebrovasodilation after hypoxia/ischemia.
    Jagolino AL; Armstead WM
    Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H101-7. PubMed ID: 12485817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M; Nykjaer A; Petersen CM; Cremona O; Pardi R; Andreasen PA; Gliemann J; Christensen EI; Blasi F
    J Cell Biol; 1995 Dec; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine prevents impairment of autoregulation after traumatic brain injury in the newborn pig through inhibition of Up-regulation of endothelin-1 and extracellular signal-regulated kinase mitogen-activated protein kinase.
    Armstead WM; Riley J; Vavilala MS
    Pediatr Crit Care Med; 2013 Feb; 14(2):e103-11. PubMed ID: 23314184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Garni-Wagner BA; Todd RF; van Zonneveld AJ; Gliemann J; Andreasen PA
    J Biol Chem; 1994 Oct; 269(41):25668-76. PubMed ID: 7929271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microparticles Impair Hypotensive Cerebrovasodilation and Cause Hippocampal Neuronal Cell Injury after Traumatic Brain Injury.
    Bohman LE; Riley J; Milovanova TN; Sanborn MR; Thom SR; Armstead WM
    J Neurotrauma; 2016 Jan; 33(2):168-74. PubMed ID: 26230045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norrin attenuates protease-mediated death of transformed retinal ganglion cells.
    Lin S; Cheng M; Dailey W; Drenser K; Chintala S
    Mol Vis; 2009; 15():26-37. PubMed ID: 19137075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
    J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
    Chintala SK
    Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The urokinase/PAI-2 complex: a new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein.
    Croucher D; Saunders DN; Ranson M
    J Biol Chem; 2006 Apr; 281(15):10206-13. PubMed ID: 16459332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-Type Plasminogen Activator-A296-299 Prevents Impairment of Cerebral Autoregulation After Stroke Through Lipoprotein-Related Receptor-Dependent Increase in cAMP and p38.
    Armstead WM; Riley J; Yarovoi S; Higazi AA; Cines DB
    Stroke; 2016 Aug; 47(8):2096-102. PubMed ID: 27354223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered release of prostaglandins contributes to hypoxic/ischemic impairment of NOC/oFQ cerebrovasodilation.
    Armstead WM
    Brain Res; 2000 Mar; 859(1):104-12. PubMed ID: 10720619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase.
    Kounnas MZ; Henkin J; Argraves WS; Strickland DK
    J Biol Chem; 1993 Oct; 268(29):21862-7. PubMed ID: 7691818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.
    Webb DJ; Thomas KS; Gonias SL
    J Cell Biol; 2001 Feb; 152(4):741-52. PubMed ID: 11266465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction.
    Nassar T; Haj-Yehia A; Akkawi S; Kuo A; Bdeir K; Mazar A; Cines DB; Higazi AA
    J Biol Chem; 2002 Oct; 277(43):40499-504. PubMed ID: 12171938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential role of PTK, ERK and p38 MAPK in superoxide impairment of NMDA cerebrovasodilation.
    Philip S; Armstead WM
    Brain Res; 2003 Jul; 979(1-2):98-103. PubMed ID: 12850576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenomedullin prevents sex-dependent impairment of autoregulation during hypotension after piglet brain injury through inhibition of ERK MAPK upregulation.
    Armstead WM; Kiessling JW; Bdeir K; Kofke WA; Vavilala MS
    J Neurotrauma; 2010 Feb; 27(2):391-402. PubMed ID: 20170313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.
    Armstead WM; Riley J; Kiessling JW; Cines DB; Higazi AA
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R480-5. PubMed ID: 20538898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NOC/oFQ activates PKC and generates superoxide to impair hypotensive cerebrovasodilation after hypoxia/ischemia.
    Armstead W
    Med Sci Monit; 2002 Jan; 8(1):BR8-BR14. PubMed ID: 11782666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway.
    Kim SY; Cheon SY; Kim EJ; Lee JH; Kam EH; Kim JM; Park M; Koo BN
    Neurochem Res; 2017 May; 42(5):1533-1542. PubMed ID: 28303501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH; Hyun MS; Kim JR
    Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.